LBO — ARISE AUSTIN MEDICAL CENTER
IRR: 30.0% | MOIC: 3.71x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
30.0%
IRR
3.71x
MOIC
$6.8M
Entry EV
$16.3M
Exit EV
$3.5M
Equity Invested
Sources & Uses
S&UTotal · $6.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $2.6M | 38.8% | |
| Sub Debt | $0.7M | 9.7% | |
| Equity | $3.5M | 51.5% | |
| Enterprise Value | $6.6M | 97.1% | |
| Transaction Fees | $0.2M | 2.9% | |
| Total Uses | $6.8M | 100.0% |
Interpretation
INTAt 3.71x MOIC and 30.0% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $1.6M |
| Exit Ev | $16.3M |
| Net Debt At Exit | $3.3M |
| Equity At Exit | $13.0M |
| Equity Invested | $3.5M |
| Total Value Created | $9.5M |
| Value From Growth | $9.3M |
| Value From Multiple | $0.3M |
| Value From Deleveraging | $0.0M |